title: CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece.
authors.forename: Spyros
authors.initials: S
authors.lastname: Pournaras
authors.forename: Alexandros
authors.initials: A
authors.lastname: Ikonomidis
authors.forename: Danai
authors.initials: D
authors.lastname: Sofianou
authors.forename: Athanassios
authors.initials: A
authors.lastname: Tsakris
authors.forename: Antonios N
authors.initials: AN
authors.lastname: Maniatis
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004926:Escherichia coli / Q000201:enzymology* / Q000235:genetics / Q000254:growth & development; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006115:Greece; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D018440:beta-Lactam Resistance / Q000235:genetics*; D001618:beta-Lactamases / Q000235:genetics / Q000378:metabolism*
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D001618:beta-Lactamases